# OnCo record mucoepidermoid-carcinoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/mucoepidermoid-carcinoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "mucoepidermoid-carcinoma" ;
  schema:name "Mucoepidermoid carcinoma"@en ;
  schema:alternateName "MEC"@en, "Mucoepidermoid carcinoma of the salivary glands"@en ;
  schema:description "Mucoepidermoid carcinoma is the most common salivary gland cancer and, for most people, one of the most curable: low-grade tumours are removed surgically and rarely return, while high-grade tumours need radiotherapy after surgery and are treated like other aggressive head and neck cancers if they spread."@en ;
  schema:url <https://onco.cc/cancers/mucoepidermoid-carcinoma/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Mucoepidermoid_carcinoma> ;
  schema:citation <https://en.wikipedia.org/wiki/Mucoepidermoid_carcinoma> ;
  onco:tag "subtype-page", "head-and-neck" ;
  onco:keyPapers <https://onco.cc/key-papers/paper-bernier-eortc-22931-nejm-2004/>, <https://onco.cc/key-papers/paper-tonon-crtc1-maml2-nat-genet-2003/>, <https://onco.cc/key-papers/paper-laurie-licitra-salivary-systemic-jco-2006/> ;
  onco:pipeline <https://onco.cc/drugs/gotistobart/>, <https://onco.cc/trials/nct05377996/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:standardOfCare <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/terms/pd-l1-testing/>, <https://onco.cc/drugs/gotistobart/>, <https://onco.cc/trials/nct05377996/> .